Edaravone Injection Shortage
Last Updated: December 5, 2024
Status: Discontinued
To Be Discontinued:
Radicava, Injection, 30 mg/100 mL (Mitsubishi Tanabe Pharma America, Inc.)
NDC Code: 70510-2171-2Status: To Be Discontinued
Date of update: December 5, 2024
Update type: New
Related Information: A business decision was made to discontinue manufacture of this product. Distribution will end as early as April 1, 2025. The discontinuation of Radicava (edaravone) injection will not impact the commercial availability of Radicava ORS (edaravone) oral su
Therapeutic category: Neurology
Date discontinued: December 5, 2024
Initial posting date: December 5, 2024
Contact info: 855-457-6968
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.